Logo image of ITHX

ITHAX ACQUISITION CORP-A (ITHX) Stock Fundamental Analysis

NASDAQ:ITHX - KYG497751027 - Common Stock

10.13 USD
-3.86 (-27.59%)
Last: 7/18/2022, 8:00:03 PM
11.59 USD
+1.46 (+14.41%)
After Hours: 7/18/2022, 8:00:03 PM
Fundamental Rating

2

ITHX gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 0 industry peers in the Unkown industry. ITHX scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. ITHX has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

ITHX had positive earnings in the past year.
ITHX Yearly Net Income VS EBIT VS OCF VS FCFITHX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 0 1M 2M 3M

1.2 Ratios

Industry RankSector Rank
ROA 1.5%
ROE 1.6%
ROIC -0.99%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ITHX Yearly ROA, ROE, ROICITHX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 0 0.5 1

1.3 Margins

ITHX does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
ITHX Yearly Profit, Operating, Gross MarginsITHX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021

More info and screens

6

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), ITHX is destroying value.
The number of shares outstanding for ITHX has been increased compared to 1 year ago.
ITHX has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
ITHX Yearly Shares OutstandingITHX Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 10M 20M 30M
ITHX Yearly Total Debt VS Total AssetsITHX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 50M 100M 150M 200M

2.2 Solvency

An Altman-Z score of 12.22 indicates that ITHX is not in any danger for bankruptcy at the moment.
There is no outstanding debt for ITHX. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 12.22
ROIC/WACC-0.11
WACC8.71%
ITHX Yearly LT Debt VS Equity VS FCFITHX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 50M 100M 150M 200M

2.3 Liquidity

A Current Ratio of 2.80 indicates that ITHX has no problem at all paying its short term obligations.
ITHX has a Quick Ratio of 2.80. This indicates that ITHX is financially healthy and has no problem in meeting its short term obligations.
Industry RankSector Rank
Current Ratio 2.8
Quick Ratio 2.8
ITHX Yearly Current Assets VS Current LiabilitesITHX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 100K 200K 300K 400K 500K

More info and screens

1

3. Growth

3.1 Past

EPS 1Y (TTM)N/A
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%215.98%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

ITHX is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 54.19% yearly.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y-233.14%
EPS Next 2Y54.19%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
ITHX Yearly Revenue VS EstimatesITHX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2022 2023 50M 100M 150M 200M 250M
ITHX Yearly EPS VS EstimatesITHX Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 0 0.1 -0.1 0.2

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 84.42, the valuation of ITHX can be described as expensive.
Compared to an average S&P500 Price/Earnings ratio of 27.17, ITHX is valued quite expensively.
A Price/Forward Earnings ratio of 39.73 indicates a quite expensive valuation of ITHX.
The average S&P500 Price/Forward Earnings ratio is at 22.78. ITHX is valued rather expensively when compared to this.
Industry RankSector Rank
PE 84.42
Fwd PE 39.73
ITHX Price Earnings VS Forward Price EarningsITHX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ITHX Per share dataITHX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6

4.3 Compensation for Growth

A more expensive valuation may be justified as ITHX's earnings are expected to grow with 54.19% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y54.19%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

ITHX does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

ITHAX ACQUISITION CORP-A

NASDAQ:ITHX (7/18/2022, 8:00:03 PM)

After market: 11.59 +1.46 (+14.41%)

10.13

-3.86 (-27.59%)

Chartmill FA Rating
GICS SectorN/A
GICS IndustryGroupN/A
GICS IndustryN/A
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners0.01%
Inst Owner Change0%
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap312.61M
Analysts82.5
Price Target13.52 (33.46%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 84.42
Fwd PE 39.73
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 1.38
P/tB N/A
EV/EBITDA N/A
EPS(TTM)0.12
EY1.18%
EPS(NY)0.26
Fwd EY2.52%
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS0
BVpS7.34
TBVpSN/A
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 1.5%
ROE 1.6%
ROCE N/A
ROIC -0.99%
ROICexc N/A
ROICexgc -0.99%
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3Y1%
ROICexcg growth 5Y0%
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.8
Quick Ratio 2.8
Altman-Z 12.22
F-Score4
WACC8.71%
ROIC/WACC-0.11
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)N/A
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%215.98%
EPS Next Y-233.14%
EPS Next 2Y54.19%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1YN/A
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3YN/A
OCF growth 5YN/A